Atlas Trials

Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021).

Clinical trial NCT03242590 · COMPLETED

Trial details

NCT number
NCT03242590
Sponsor
Lipocine Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypogonadism, Male
Start date
2016-12-01
Primary completion
2017-03-01
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.